Clinical Trial Update: A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer [NA]

View source ↗

Summary

This completed randomized, placebo-controlled study evaluated the safety and potential efficacy of MS-20 in combination with pembrolizumab for non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• MS-20
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Microbio Co Ltd | Conditions: NSCLC Stage IIIB~IV | NA | Status: COMPLETED